Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP343742.RAuuVMFXTXnU8Co-YKvXNY0_gQZQrz-8g9SFP35rIjXsA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP343742.RAuuVMFXTXnU8Co-YKvXNY0_gQZQrz-8g9SFP35rIjXsA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP343742.RAuuVMFXTXnU8Co-YKvXNY0_gQZQrz-8g9SFP35rIjXsA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP343742.RAuuVMFXTXnU8Co-YKvXNY0_gQZQrz-8g9SFP35rIjXsA130_provenance.
- NP343742.RAuuVMFXTXnU8Co-YKvXNY0_gQZQrz-8g9SFP35rIjXsA130_assertion description "[We conducted a retrospective review of the results of urinary steroid profiling (USP) by GC-MS and mutational analysis of SRD5A2 [steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)] by PCR and direct DNA sequencing of all 46,XY DSD patients referred to our laboratory with biochemical and/or genetic findings compatible with 5ARD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343742.RAuuVMFXTXnU8Co-YKvXNY0_gQZQrz-8g9SFP35rIjXsA130_provenance.
- NP343742.RAuuVMFXTXnU8Co-YKvXNY0_gQZQrz-8g9SFP35rIjXsA130_assertion evidence source_evidence_literature NP343742.RAuuVMFXTXnU8Co-YKvXNY0_gQZQrz-8g9SFP35rIjXsA130_provenance.
- NP343742.RAuuVMFXTXnU8Co-YKvXNY0_gQZQrz-8g9SFP35rIjXsA130_assertion SIO_000772 23513070 NP343742.RAuuVMFXTXnU8Co-YKvXNY0_gQZQrz-8g9SFP35rIjXsA130_provenance.
- NP343742.RAuuVMFXTXnU8Co-YKvXNY0_gQZQrz-8g9SFP35rIjXsA130_assertion wasDerivedFrom befree-20140225 NP343742.RAuuVMFXTXnU8Co-YKvXNY0_gQZQrz-8g9SFP35rIjXsA130_provenance.
- NP343742.RAuuVMFXTXnU8Co-YKvXNY0_gQZQrz-8g9SFP35rIjXsA130_assertion wasGeneratedBy ECO_0000203 NP343742.RAuuVMFXTXnU8Co-YKvXNY0_gQZQrz-8g9SFP35rIjXsA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP343742.RAuuVMFXTXnU8Co-YKvXNY0_gQZQrz-8g9SFP35rIjXsA130_provenance.